Search - tctmd.com

Displaying 381 - 400 of 696

Sort: Relevancy | Date

News Conference News SCCT 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Yael L. Maxwell

July 22, 2020

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Daily News

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Michael O'Riordan

June 22, 2020

News Daily News

Had COVID-19? ‘Hidden’ CV Damage Warrants Cautious Return to Physical Activity

Michael O'Riordan

June 17, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

L.A. McKeown

May 28, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

L.A. McKeown

May 05, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Opinion CV Team Dispatch

April 2020 News Roundup

L.A. McKeown

April 10, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

Advertisement

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Device Explants After TAVR Rare but Risky

Too Many HF Trial Results Underreported or Never Published

Rural-Urban Gap Widens for Cardiometabolic Health Disparities

Had COVID-19? ‘Hidden’ CV Damage Warrants Cautious Return to Physical Activity

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

April 2020 News Roundup

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content